Home Biosimilar Antibodies Microbiology SARS-CoV antibody Lenzilumab (Anti-CSF2 / GM-CSF)
For research use only. Not for use in humans.

Lenzilumab (Anti-CSF2 / GM-CSF)

Synonyms: KB 003

Lenzilumab (Anti-CSF2 / GM-CSF) is a recombinant monoclonal antibody against the cytokine granulocyte macrophage colony-stimulating factor (GM-CSF), with potential immunomodulating activity. MW: 145.72 KD.

Lenzilumab (Anti-CSF2 / GM-CSF)

Quality Control

Batch: A285401 Purity: 99% Protein concentration: 10.33mg/ml Endotoxin Level: ＜1EU/mg
99

Specificity

Name Citation SARS-CoV-2 Others
Simnotrelvir 0
Ensitrelvir fumarate 1
GS-621763 0
Bemnifosbuvir Hemisulfate (AT-527) 0
XP-59 0
Coronastat(NK01-63) 0
Paquinimod (ABR-215757) 3
Molnupiravir (EIDD-2801) 13 MERS-CoV
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Mechanism of Action

Description
Lenzilumab (Anti-CSF2 / GM-CSF) is a recombinant monoclonal antibody against the cytokine granulocyte macrophage colony-stimulating factor (GM-CSF), with potential immunomodulating activity. MW: 145.72 KD.
References

Product Details

CAS No. 1229575-09-0
Molecular Weight 145.72
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.